Mi-RNA and COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), induces a spectrum of clinical conditions ranging from asymptomatic infection to life threatening severe disease, characterized by respiratory failure, shock and multi-organ dysfunction requiring admission in the intensive care unit (ICU). The aim of the present study is to analyze miRNAs associated with SARS-CoV-2 infection, disease severity and mortality.

NCT Number	NCT06881160
Lead Sponsor	Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions	COVID-19
Enrollment	49 participants
Start Date	2020-03-01
Primary Completion	2025-12-31 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-03-18